Diffusion Pharmaceuticals
DFFN
#10344
Rank
C$12.4 M
Marketcap
C$6.08
Share price
10.28%
Change (1 day)
-37.29%
Change (1 year)

Earnings for Diffusion Pharmaceuticals (DFFN)

Earnings in 2023 (TTM): -C$17.72 Million

According to Diffusion Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -C$21.55 Million, an increase over its 2021 earnings that were of -C$33.92 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Diffusion Pharmaceuticals from 1999 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -C$17.72 Million-17.77%
2022 -C$21.55 Million-36.46%
2021 -C$33.92 Million54.72%
2020 -C$21.93 Million38.32%
2019 -C$15.85 Million-39.03%
2018 -C$26 Million677.09%
2017 -C$3.35 Million-86.85%
2016 -C$25.44 Million-22.75%
2015 -C$32.93 Million38.74%
2014 -C$23.74 Million598.54%
2013 -C$3.4 Million-57.56%
2012 -C$8.01 Million-62.43%
2011 -C$21.31 Million58.75%
2010 -C$13.43 Million238.41%
2009 -C$3.97 Million189.55%
2008 -C$1.37 Million1576.75%
2007 -C$0.09 Million-35.01%
2006 -C$0.13 Million
1999 -C$10.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-C$0.21 Billion 1,031.69%๐Ÿ‡บ๐Ÿ‡ธ USA